BRAVA CRT-D,CONCERTO II CRT-D,CONSULTA ICD,MAXIMO II CRT-D,PROTECTA CRT-D,PROTECTA XT CRT-D,VIVA S CRT-D
FDA premarket approval P010031/S431 · decided 2014-04-04
Approval details
- PMA number
- P010031
- Supplement
- S431
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA CRT-D,CONCERTO II CRT-D,CONSULTA ICD,MAXIMO II CRT-D,PROTECTA CRT-D,PROTECTA XT CRT-D,VIVA S CRT-D
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-03-07
- Decision date
- 2014-04-04
- Days to decision
- 28 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- MANUFACTURING PROCESS CHANGE FOR THE PRINTED WIRING BOARD (PWB) SUBSTRATES AT A MEDTRONIC SECOND TIER SUPPLIER. THESE PWB SUBSTRATES ARE USED IN THE MANUFACTURE OF HYBRID SUBSTRATES AT MEDTRONIC¿S INTERNAL SUPPLIER, MEDTRONIC TEMPE CAMPUS (MTC), FOR THE DEVICES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.